富血小板血浆联合仙灵骨葆胶囊治疗大鼠膝骨关节炎的应用研究

蔡振华, 肖木洲, 罗恒, 吴芝兰, 李丽, 吕聪

PDF(1993 KB)
PDF(1993 KB)
重庆医科大学学报 ›› 2025, Vol. 50 ›› Issue (05) : 623-629. DOI: 10.13406/j.cnki.cyxb.003811
基础研究

富血小板血浆联合仙灵骨葆胶囊治疗大鼠膝骨关节炎的应用研究

作者信息 +

Application of platelet-rich plasma combined with Xianling Gubao Capsule in treatment of rats with knee osteoarthritis

Author information +
History +

摘要

目的 探讨富血小板血浆(platelet-rich plasma,PRP)联合仙灵骨葆胶囊对大鼠骨关节炎(osteoarthritis,OA)的治疗效果及相关因子水平变化。 方法 使用前交叉韧带横断手术构建大鼠骨关节炎模型,模型建立之后将大鼠随机分为对照组(n=10)、模型组(n=10)、仙灵骨葆胶囊组(n=10)、PRP组(n=10)和仙灵骨葆胶囊联合PRP组(n=10)。干预结束后,采用酶联免疫吸附测定(enzyme linked immunosorbent assay,ELISA)检测大鼠血清中白细胞介素-1β(interleukin-1 beta,IL-1β)和肿瘤坏死因子-α(tumor necrosis factor alpha,TNF-α)的水平;取大鼠膝关节软骨,通过qPCR和Western blot检测MMP3、MMP13、Col2、Aggrecan和p-p38基因和蛋白的表达水平;Micro-CT评估大鼠膝关节周围骨变化情况;HE染色和SF染色观察大鼠膝关节软骨变化。 结果 ELISA结果显示,PRP联合仙灵骨葆胶囊治疗后显著降低了大鼠血清中IL-1β和TNF-α等炎性因子水平,差异有统计学意义(P<0.05)。qPCR和Western blot结果显示PRP联合仙灵骨葆胶囊治疗明显降低大鼠膝关节软骨中MMP3、MMP13、p-p38的表达降低,增加Col2和Aggrecan的表达,差异有统计学意义(P<0.05)。Micro-CT、HE染色和SF染色结果显示,PRP联合仙灵骨葆胶囊组大鼠膝关节软骨退变在一定程度得到改善,差异有统计学意义(P<0.05)。 结论 PRP联合仙灵骨葆胶囊能有效治疗大鼠OA,其机制可能是通过调控p38MAPK信号通路来实现的。

Abstract

Objective To investigate the therapeutic effect of platelet-rich plasma(PRP) combined with Xianling Gubao Capsule on rats with osteoarthritis(OA) and the changes in the levels of related factors. Methods Anterior cruciate ligament transection was performed to establish a rat model of OA,and after modeling,the rats were randomly divided into control group,model group,Xianling Gubao Capsule group,PRP group,and Xianling Gubao Capsule+PRP group,with 10 rats in each group. After intervention,ELISA was used to measure the serum levels of IL-1β and TNF-α; knee articular cartilage was collected,and qPCR and Western blot were used to measure the mRNA and protein expression levels of MMP3,MMP13,Col2,Aggrecan,and p-p38; Micro-CT was used to assess the changes in bones around the knee joint; HE staining and SF staining were used to observe the changes in knee articular cartilage. Results ELISA showed that PRP combined with Xianling Gubao Capsule significantly reduced the serum levels of the inflammatory factors such as IL-1β and TNF-α(P<0.05). The results of qPCR and Western blot showed that PRP combined with Xianling Gubao Capsule significantly reduced the expression levels of MMP3,MMP13,and p-p38 and increased the expression levels of Col2 and Aggrecan in knee articular cartilage(P<0.05). Micro-CT,HE staining,and SF staining showed a certain degree of improvement in knee articular cartilage degeneration in the Xianling Gubao Capsule+PRP group (P<0.05). Conclusion PRP combined with Xianling Gubao Capsule exerts a therapeutic effect on rats with OA,possibly by regulating the p38MAPK signaling pathway.

关键词

骨关节炎 / 富血小板血浆 / 仙灵骨葆胶囊 / p38丝裂原活化蛋白激酶

Key words

osteoarthritis / platelet-rich plasma / Xianling Gubao Capsule / p38 mitogen-activated protein kinase

中图分类号

R114

引用本文

导出引用
蔡振华 , 肖木洲 , 罗恒 , . 富血小板血浆联合仙灵骨葆胶囊治疗大鼠膝骨关节炎的应用研究. 重庆医科大学学报. 2025, 50(05): 623-629 https://doi.org/10.13406/j.cnki.cyxb.003811
Cai Zhenhua, Xiao Muzhou, Luo Heng, et al. Application of platelet-rich plasma combined with Xianling Gubao Capsule in treatment of rats with knee osteoarthritis[J]. Journal of Chongqing Medical University. 2025, 50(05): 623-629 https://doi.org/10.13406/j.cnki.cyxb.003811

参考文献

1
Abramoff B Caldera FE. Osteoarthritis:pathology,diagnosis,and treatment options[J]. Med Clin North Am2020104(2):293-311.
2
Diamond LE Grant T Uhlrich SD. Osteoarthritis year in review 2023:biomechanics[J]. Osteoarthritis Cartilage202432(2):138-147.
3
Minnig MCC Golightly YM Nelson AE. Epidemiology of osteoarthritis:literature update 2022-2023[J]. Curr Opin Rheumatol202436(2):108-112.
4
Sampath SJP Venkatesan V Ghosh S,et al. Obesity,metabolic syndrome,and osteoarthritis-an updated review[J]. Curr Obes Rep202312(3):308-331.
5
刘应泉,姜丁铭,严 铮,等. 从“虚、瘀、痰、郁” 探讨绝经后膝骨关节炎合并骨质疏松症病机特点[J]. 中国骨质疏松杂志202430(2):290-294,312.
Liu YQ Jiang DM Yan Z,et al. The etiology and pathogenesis of postmenopausal knee osteoarthritis complicated with osteoporosis discussed from weakness,stasis,phlegm,and depression[J]. Chin J Osteoporos202430(2):290-294,312.
6
商岚清,周广智,程鑫雨,等. 仙灵骨葆胶囊针对膝骨关节炎疗效及安全性系统评价与荟萃分析[J]. 辽宁中医药大学学报202426(4):132-139
Shang LQ Zhou GZ Cheng XY,et al. Systematic evaluation and meta-analysis of the efficacy and safety of xianling gubao capsule in the treatment of knee osteoarthritis[J]. J Liaoning Univ Tradit Chin Med202426(4):132-139.
7
Bennell KL Paterson KL Metcalf BR,et al. Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis:the RESTORE randomized clinical trial[J]. JAMA2021326(20):2021-2030.
8
Filardo G Previtali D Napoli F,et al. PRP injections for the treatment of knee osteoarthritis:a meta-analysis of randomized controlled trials[J]. Cartilage202113(Suppl):S364-S375.
9
Wang ZC Zhu PF Liao BK,et al. Effects and action mechanisms of individual cytokines contained in PRP on osteoarthritis[J]. J Orthop Surg Res202318(1):713.
10
Paget LDA Reurink G de Vos RJ,et al. Platelet-rich plasma injections for the treatment of ankle osteoarthritis[J]. Am J Sports Med202351(10):2625-2634.
11
Bacevich BM Smith RDJ Reihl AM,et al. Advances with platelet-rich plasma for bone healing[J]. Biologics202418:29-59.
12
Guo HL Yin WF Zou ZL,et al. Quercitrin alleviates cartilage extracellular matrix degradation and delays ACLT rat osteoarthritis development:an in vivo and in vitro study[J]. J Adv Res202028:255-267.
13
Landesberg R Roy M Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation[J]. J Oral Maxillofac Surg200058(3):297-300;discussion 300-301.
14
Richard MJ Driban JB McAlindon TE. Pharmaceutical treatment of osteoarthritis[J]. Osteoarthritis Cartilage202331(4):458-466.
15
da Costa BR Pereira TV Saadat P,et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis:network meta-analysis[J]. BMJ2021375:n2321.
16
张茜玥,李昀姝,赵杰瑞,等. 中医药联合富血小板血浆治疗膝骨关节炎进展[J]. 中药材202447(1):261-267.
Zhang XY Li YS Zhao JR,et al. J Chin Med Mater202447(1):261-267.
17
Knights AJ Redding SJ Maerz T. Inflammation in osteoarthritis:the latest progress and ongoing challenges[J]. Curr Opin Rheumatol202335(2):128-134.
18
丁 童,周彦鹏,冯立平. 长链非编码RNA MEG3靶向下调miR-21对IL-1β诱导的软骨细胞凋亡及炎症反应的影响[J]. 中国骨质疏松杂志202026(4):515-523.
Ding T Zhou YP Feng LP. The effects of long non-coding RNA MEG3 on IL-1β-induced cell apoptosis and inflammatory response of chondrocytes by targeting miR-21[J]. Chin J Osteoporos202026(4):515-523.
19
刘元豪,邢 忠,许环顺,等. 重楼皂苷VII对IL-1β诱导的关节软骨细胞凋亡和分泌炎症介质的影响[J]. 中国骨质疏松杂志202329(3):330-335.
Liu YH Xing Z Xu HS,et al. Effects of polyphyllin VII on IL-1β-induced apoptosis and secretion of inflammatory mediators[J]. Chin J Osteoporos202329(3):330-335.
20
Wang ZC Zhu PF Liao BK,et al. Effects and action mechanisms of individual cytokines contained in PRP on osteoarthritis[J]. J Orthop Surg Res202318(1):713.
21
Zhang Y Wang XW Chen J,et al. Exosomes derived from platelet-rich plasma administration in site mediate cartilage protection in subtalar osteoarthritis[J]. J Nanobiotechnology202220(1):56.
22
习文青. 仙灵骨葆胶囊治疗膝骨关节炎的Meta分析和网络药理学研究[D]. 北京:北京中医药大学,2022.
Xi WQ. Meta-analysis and network pharmacology study of Xianlinggubao capsule in the treatment of knee osteoarthritis[D]. Beijing:Beijing University of Chinese Medicine,2022.
23
魏林.PRP干预对KOA模型大鼠软骨IL-6、TNF-α及p38MAPK的影响[D].成都:成都体育学院,2023.
Wei L. The Effects of PRP Intervention on IL-6,TNF-α,and p38MAPK in Cartilage of OA Rat Model [D]. Chengdu:Chengdu Sport University,2023.
24
张奇先,丁 爽,吴前. 仙灵骨葆胶囊对大鼠膝骨关节炎的治疗作用及机制[J]. 解剖科学进展202228(1):100-103,108.
Zhang QX Ding S Wu Q. Therapeutical effect and mechanism of Xian-Ling-gu-Bao capsule on knee osteoarthritis in rats[J]. Prog Anat Sci202228(1):100-103,108.
25
Hu Y Chen X Wang SC,et al. Subchondral bone microenvironment in osteoarthritis and pain[J]. Bone Res20219(1):20.
26
Zhang H Cai D Bai X. Macrophages regulate the progression of osteoarthritis[J]. Osteoarthritis Cartilage202028(5):555-561.
27
Luo YY Sinkeviciute D He Y,et al. The minor collagens in articular cartilage[J]. Protein Cell20178(8):560-572.
28
Kim EK Choi EJ. Compromised MAPK signaling in human diseases:an update[J]. Arch Toxicol201589(6):867-882.
29
Sondergaard BC Schultz N Madsen SH,et al. MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation:divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation[J]. Osteoarthritis Cartilage201018(3):279-288.
30
Zhou F Mei JT Han XG,et al. Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-κB/MAPK signaling and protecting chondrocytes[J]. Acta Pharm Sin B20199(5):973-985.

基金

广东省中医药局科研资助项目(20241110)

评论

PDF(1993 KB)

Accesses

Citation

Detail

段落导航
相关文章

/